Nov 04, 2022 / 12:30PM GMT
Operator
Hello, and welcome to the Medicenna Therapeutics Fiscal Second Quarter Earnings Call. (Operator Instructions) Please be advised this call is being recorded at the company's request. I would now like to turn the call over to Dan Ferry of LifeSci Advisors. Please go ahead.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Thank you, operator, and thank you all for participating in today's conference call. This morning, Medicenna issued a press release providing financial results and corporate updates for the quarter ended September 30, 2022. If you have not yet seen the press release, it is available on the Investor page of Medicenna's website. Before we begin, I would like to remind you that certain statements and information shared during this call constitute forward-looking information within the meaning of applicable securities laws.
All statements other than statements of historical facts shared during this call and that relate to the future operations of the company and other statements that are not historical facts, including
Q2 2023 Medicenna Therapeutics Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot